Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

PURPOSE: The long-term risk of prostate cancer–specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA) screening. Models that predict the risk of PCSM are needed for patient counseling and clinical trial de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stephenson, Andrew J., Kattan, Michael W., Eastham, James A., Bianco, Fernando J., Yossepowitch, Ofer, Vickers, Andrew J., Klein, Eric A., Wood, David P., Scardino, Peter T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651598/
https://ncbi.nlm.nih.gov/pubmed/19636023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.2501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados